Recruiting Melanoma Studies in Bethesda
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
This is a Phase 3, multicenter, open-label, randomized, parallel group, treatment study to assess the efficacy and safety of lifileucel in combination with pembrolizumab compared with pembrolizumab al...
Dabrafenib and/or Trametinib Rollover Study
This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development, Global Medical Affairs or a former GSK-s...
About Melanoma Clinical Trials in Bethesda
Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.
There are currently 2 melanoma clinical trials recruiting participants in Bethesda, MARYLAND. These studies are seeking a combined 770 participants. Research is being sponsored by Iovance Biotherapeutics, Inc., Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Melanoma Clinical Trials in Bethesda — FAQ
Are there melanoma clinical trials in Bethesda?
Yes, there are 2 melanoma clinical trials currently recruiting in Bethesda, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Bethesda?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bethesda research site will contact you about next steps.
Are clinical trials in Bethesda free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bethesda studies also compensate for your time and travel.
What melanoma treatments are being tested?
The 2 active trials in Bethesda are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.
Data updated March 2, 2026 from ClinicalTrials.gov